This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Nov. 8, 2013 /PRNewswire/ -- Harwood Feffer LLP (
www.hfesq.com) is investigating potential claims against the board of directors of Santarus, Inc. ("Santarus" or the "Company") (NASDAQ: SNTS) concerning the proposed acquisition of the Company by Salix Pharmaceuticals, Ltd. ("Salix").